아베난쓰라마이드 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Avenanthramides Market Summary

The global avenanthramides market size was estimated at USD 145.1 million in 2025 and is projected to reach USD 295.0 million, growing at a CAGR of 9.5% from 2026 to 2033. Demand for avenanthramides is increasing as the cosmetic, pharmaceutical, and nutraceutical industries look for natural, evidence-based anti-inflammatory ingredients.

Patents and clinical advancements support this growth, while rising consumer preference for oat-derived actives further boosts adoption. Limited availability of raw materials and complex extraction processes keep prices and margins high, which, in turn, drive greater investment in specialized processing capacity. Consumers increasingly prefer natural, clinically validated ingredients, while formulators value avenanthramides for their combined antioxidant and anti-inflammatory benefits. Pharmaceutical interest is also expanding as early clinical findings indicate a strong safety profile. Premium positioning supports higher margins, which encourages ingredient manufacturers and biotech firms to invest in advanced extraction techniques, standardization, and stability research. Demand is strongest in North America, Europe, and the Asia Pacific, where regulatory systems and skincare markets are well established.

However, growth is constrained by the limited availability of oat bran rich in avenanthramides, variability in phytochemical yields across cultivars, and the high cost of purification. Smaller suppliers often face challenges in scaling GMP production, whereas larger companies secure intellectual property rights and long-term supply agreements to maintain market share. Strategic research partnerships and contract manufacturing help reduce supply risks and accelerate commercialization, while investors continue to support expansion and scale-up initiatives.

The rising preference for personalized beauty and nutrition solutions is driving demand further. Brands are reformulating products with targeted bioactive compounds that address concerns such as sensitive skin, eczema, and lifestyle-related inflammation. In addition, sustainability trends are shaping adoption as oat cultivation has a relatively low environmental impact. This aligns well with clean-label and eco-conscious initiatives, strengthening consumer trust, enabling premium pricing, and reinforcing avenanthramides as a key ingredient in advanced skincare and functional health products.

Global Avenanthramides Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global avenanthramides market report based on product, end use, and region.

• Product Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
• Natural
• Synthetic
• End Use Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
• Personal Care & Cosmetics
• Pharmaceuticals
• Animal Health
• Other End Use
• Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
• 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Avenanthramides Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Avenanthramides Market Outlook
• 3.2. Industry Value Chain Analysis
  • 3.2.1. Raw Material Outlook
  • 3.2.2. Manufacturing Trends
  • 3.2.3. Sales Channel Analysis
• 3.3. Price Trend Analysis, 2021-2033
  • 3.3.1. Factor Influencing Prince Trends
• 3.4. Regulatory Framework
• 3.5. Market Dynamics
  • 3.5.1. Market Driver Analysis
  • 3.5.2. Market Restraint Analysis
  • 3.5.3. Industry Challenges
  • 3.5.4. Industry Opportunities
• 3.6. Industry Analysis Tools
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. Macro-Environmental Analysis

Chapter 4. Avenanthramides Market: Product Estimates & Trend Analysis

• 4.1. Product Movement Analysis & Market Share, 2023 & 2033
• 4.2. Natural
  • 4.2.1. Natural Avenanthramides Market Estimates & Forecast, By Product, 2021 To 2033 (Kilotons) (USD Million)
• 4.3. Synthetic
  • 4.3.1. Synthetic Avenanthramides Market Estimates & Forecast, By Product, 2021 To 2033 (Kilotons) (USD Million)

Chapter 5. Avenanthramides Market: End Use Estimates & Trend Analysis

• 5.1. End Use Movement Analysis & Market Share, 2023 & 2033
• 5.2. Personal Care & Cosmetics
  • 5.2.1. Personal Care & Cosmetics Avenanthramides Market Estimates & Forecast, By End Use, 2021 To 2033 (Kilotons) (USD Million)
• 5.3. Pharmaceuticals
  • 5.3.1. Pharmaceuticals Avenanthramides Market Estimates & Forecast, By End Use, 2021 To 2033 (Kilotons) (USD Million)
• 5.4. Animal Health
  • 5.4.1. Animal Health Avenanthramides Market Estimates & Forecast, By End Use, 2021 To 2033 (Kilotons) (USD Million)
• 5.5. Other End Use
  • 5.5.1. Other End Use Avenanthramides Market Estimates & Forecast, By End Use, 2021 To 2033 (Kilotons) (USD Million)

Chapter 6. Avenanthramides Market: Regional Estimates & Trend Analysis

• 6.1. Regional Movement Analysis & Market Share, 2023 & 2033
• 6.2. North America
  • 6.2.1. North America Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
  • 6.2.2. North America Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
  • 6.2.3. U.S.
    • 6.2.3.1. Key Country Dynamics
    • 6.2.3.2. U.S. Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
    • 6.2.3.3. U.S. Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
  • 6.2.4. Canada
    • 6.2.4.1. Key Country Dynamics
    • 6.2.4.2. Canada Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
    • 6.2.4.3. Canada Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
  • 6.2.5. Mexico
    • 6.2.5.1. Key Country Dynamics
    • 6.2.5.2. Mexico Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
    • 6.2.5.3. Mexico Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
• 6.3. Europe
  • 6.3.1. Europe Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
  • 6.3.2. Europe Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
  • 6.3.3. Germany
    • 6.3.3.1. Key Country Dynamics
    • 6.3.3.2. Germany Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
    • 6.3.3.3. Germany Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
  • 6.3.4. UK
    • 6.3.4.1. Key Country Dynamics
    • 6.3.4.2. UK Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
    • 6.3.4.3. UK Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
  • 6.3.5. France
    • 6.3.5.1. Key Country Dynamics
    • 6.3.5.2. France Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
    • 6.3.5.3. France Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
  • 6.3.6. Italy
    • 6.3.6.1. Key Country Dynamics
    • 6.3.6.2. Italy Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
    • 6.3.6.3. Italy Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
  • 6.3.7. Spain
    • 6.3.7.1. Key Country Dynamics
    • 6.3.7.2. Spain Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
    • 6.3.7.3. Spain Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
  • 6.4.2. Asia Pacific Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
  • 6.4.3. China
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. China Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
    • 6.4.3.3. China Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
  • 6.4.4. India
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. India Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
    • 6.4.4.3. India Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
  • 6.4.5. Japan
    • 6.4.5.1. Key Country Dynamics
    • 6.4.5.2. Japan Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
    • 6.4.5.3. Japan Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
  • 6.4.6. South Korea
    • 6.4.6.1. Key Country Dynamics
    • 6.4.6.2. South Korea Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
    • 6.4.6.3. South Korea Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
  • 6.5.2. Latin America Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
  • 6.5.3. Brazil
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Brazil Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
    • 6.5.3.3. Brazil Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
  • 6.5.4. Argentina
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Argentina Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
    • 6.5.4.3. Argentina Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
• 6.6. Middle East & Africa
  • 6.6.1. Middle East & Africa Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
  • 6.6.2. Middle East & Africa Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
  • 6.6.3. Saudi Arabia
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Saudi Arabia Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
    • 6.6.3.3. Saudi Arabia Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)
  • 6.6.4. South Africa
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. South Africa Avenanthramides Estimates & Forecast, By Product, 2021 - 2033 (Kilotons) (USD Million)
    • 6.6.4.3. South Africa Avenanthramides Estimates & Forecast, By End Use, 2021 - 2033 (Kilotons) (USD Million)

Chapter 7. Avenanthramides Market - Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Market Share/Position Analysis, 2025
• 7.4. Company Heat Map Analysis
• 7.5. Strategy Mapping
• 7.6. Company Profiles
  • 7.6.1. Ceapro Inc.
    • 7.6.1.1. Participant's Overview
    • 7.6.1.2. Financial Performance
    • 7.6.1.3. Product Benchmarking
    • 7.6.1.4. Recent Developments
  • 7.6.2. Cosciens Biopharma Inc.
    • 7.6.2.1. Participant's Overview
    • 7.6.2.2. Financial Performance
    • 7.6.2.3. Product Benchmarking
    • 7.6.2.4. Recent Developments
  • 7.6.3. Chemicea Pharma
    • 7.6.3.1. Participant's Overview
    • 7.6.3.2. Financial Performance
    • 7.6.3.3. Product Benchmarking
    • 7.6.3.4. Recent Developments
  • 7.6.4. Symrise AG
    • 7.6.4.1. Participant's Overview
    • 7.6.4.2. Financial Performance
    • 7.6.4.3. Product Benchmarking
    • 7.6.4.4. Recent Developments
  • 7.6.5. Chen Lan gBio
    • 7.6.5.1. Participant's Overview
    • 7.6.5.2. Financial Performance
    • 7.6.5.3. Product Benchmarking
    • 7.6.5.4. Recent Developments
  • 7.6.6. Henan Steeda Industrial Co., Ltd.
    • 7.6.6.1. Participant's Overview
    • 7.6.6.2. Financial Performance
    • 7.6.6.3. Product Benchmarking
    • 7.6.6.4. Recent Developments
  • 7.6.7. BioCrick
    • 7.6.7.1. Participant's Overview
    • 7.6.7.2. Financial Performance
    • 7.6.7.3. Product Benchmarking
    • 7.6.7.4. Recent Developments